Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 7.28 is 10% below its 5-year average of 8.13, around the middle of its 5-year range (4.92–11.54).
As of the fiscal period ended Tuesday, June 30, 2026. 12.95% below its 12-month average of 8.37.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.28.
CURRENT RATIO
7.28
CURRENT RATIO AVG TTM
8.37
CURRENT RATIO AVG 3Y
7.60
CURRENT RATIO AVG 5Y
8.13
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-12.95%
CURRENT VS 3Y AVG
-4.11%
CURRENT VS 5Y AVG
-10.40%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.08
median of 455 covered companies
CURRENT VS SECTOR MEDIAN
+136.48%
vs the sector median at left
Black Diamond Therapeutics, Inc.
Market Cap
$111.17M
Current Ratio
7.28
TTM Avg
8.37
3Y Avg
7.60
5Y Avg
8.13
Market Cap
$109.49M
Current Ratio
5.68
TTM Avg
5.13
3Y Avg
4.85
5Y Avg
5.20
Market Cap
$113.77M
Current Ratio
13.40
TTM Avg
10.04
3Y Avg
7.53
5Y Avg
8.95
Market Cap
$108.39M
Current Ratio
5.71
TTM Avg
10.50
3Y Avg
6.63
5Y Avg
5.88
Market Cap
$114.24M
Current Ratio
12.63
TTM Avg
12.83
3Y Avg
15.22
5Y Avg
15.22
Market Cap
$106.23M
Current Ratio
0.96
TTM Avg
1.08
3Y Avg
1.26
5Y Avg
1.56
Market Cap
$117.43M
Current Ratio
3.36
TTM Avg
3.23
3Y Avg
4.24
5Y Avg
6.08
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | $111.17M | 7.28 | 8.37 | 7.60 | 8.13 |
| Immunic, Inc. (IMUX)vs › | $109.93M | 5.05 | 1.26 | 3.56 | 6.57 |
| Apyx Medical Corporation (APYX)vs › | $109.49M | 5.68 | 5.13 | 4.85 | 5.20 |
| Coya Therapeutics, Inc. (COYA)vs › | $113.77M | 13.40 | 10.04 | 7.53 | 8.95 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.39M | 5.71 | 10.50 | 6.63 | 5.88 |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $114.24M | 12.63 | 12.83 | 15.22 | 15.22 |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.23M | 0.96 | 1.08 | 1.26 | 1.56 |
| Genelux Corporation (GNLX)vs › | $116.59M | 2.39 | 3.50 | 2.69 | 1.97 |
| Foghorn Therapeutics Inc. (FHTX)vs › | $117.43M | 3.36 | 3.23 | 4.24 | 6.08 |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | 6.49 | 6.44 | 8.52 | 8.53 |
Current Ratio
7.28
Quick Ratio
7.28
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 7.28 |
| 2026-03-31 | 8.46 |
| 2025-12-31 | 8.42 |
| 2025-09-30 | 8.94 |
| 2025-06-30 | 8.73 |
| 2025-03-31 | 9.24 |
| 2024-12-31 | 4.92 |
| 2024-09-30 | 5.55 |
| 2024-06-30 | 6.87 |
| 2024-03-31 | 7.05 |
| 2023-12-31 | 6.82 |
| 2023-09-30 | 9.76 |
| 2023-06-30 | 6.69 |
| 2023-03-31 | 8.40 |
| 2022-12-31 | 8.37 |
| 2022-09-30 | 7.14 |
| 2022-06-30 | 8.55 |
| 2022-03-31 | 9.67 |
| 2021-12-31 | 9.12 |
| 2021-09-30 | 9.16 |
| 2021-06-30 | 11.54 |
| 2021-03-31 | 15.90 |
| 2020-12-31 | 22.48 |
| 2020-09-30 | 29.66 |
| 2020-06-30 | 33.92 |
| 2020-03-31 | 49.60 |
| 2019-12-31 | 32.02 |
| 2019-09-30 | 16.99 |
| 2019-06-30 | 26.25 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 20.07 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
